As of 2024-12-12, the Relative Valuation of Amicus Therapeutics Inc (FOLD) is (9.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.16 USD, the upside of Amicus Therapeutics Inc based on Relative Valuation is -195.2%.
The range of the Relative Valuation is (9.86) - (10.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.1x - 40.9x | 34.7x |
| Forward P/E multiples | 19.8x - 29.5x | 20.5x |
| Fair Price | (9.86) - (10.35) | (9.67) |
| Upside | -197.0% - -201.9% | -195.2% |
| Date | P/E |
| 2024-12-11 | -29.00 |
| 2024-12-10 | -28.91 |
| 2024-12-09 | -28.06 |
| 2024-12-06 | -27.77 |
| 2024-12-05 | -27.86 |
| 2024-12-04 | -28.14 |
| 2024-12-03 | -27.94 |
| 2024-12-02 | -28.43 |
| 2024-11-29 | -28.49 |
| 2024-11-27 | -28.43 |
| 2024-11-26 | -28.17 |
| 2024-11-25 | -27.74 |
| 2024-11-22 | -27.57 |
| 2024-11-21 | -27.12 |
| 2024-11-20 | -27.37 |
| 2024-11-19 | -27.17 |
| 2024-11-18 | -27.57 |
| 2024-11-15 | -27.63 |
| 2024-11-14 | -28.80 |
| 2024-11-13 | -29.60 |
| 2024-11-12 | -29.94 |
| 2024-11-11 | -30.51 |
| 2024-11-08 | -31.37 |
| 2024-11-07 | -31.34 |
| 2024-11-06 | -32.08 |
| 2024-11-05 | -33.51 |
| 2024-11-04 | -32.34 |
| 2024-11-01 | -32.74 |
| 2024-10-31 | -32.60 |
| 2024-10-30 | -33.05 |
| 2024-10-29 | -32.80 |
| 2024-10-28 | -32.88 |
| 2024-10-25 | -33.37 |
| 2024-10-24 | -33.57 |
| 2024-10-23 | -32.54 |
| 2024-10-22 | -33.88 |
| 2024-10-21 | -34.28 |
| 2024-10-18 | -33.97 |
| 2024-10-17 | -34.17 |
| 2024-10-16 | -29.97 |
| 2024-10-15 | -29.43 |
| 2024-10-14 | -29.74 |
| 2024-10-11 | -29.97 |
| 2024-10-10 | -28.69 |
| 2024-10-09 | -29.00 |
| 2024-10-08 | -28.66 |
| 2024-10-07 | -29.17 |
| 2024-10-04 | -30.26 |
| 2024-10-03 | -30.14 |
| 2024-10-02 | -30.23 |